Summary
- World-first cancer treatment from Melbourne added to Pharmaceutical Benefits Scheme
- Treatment involves two drugs, Imbruvica and Venetoclax, taken together to combat blood cancer
- Price of the pill slashed from $12,600 a month to $7.70 for concession card holders and $31.60 for general patients
- Health Minister Mark Butler calls the treatment “remarkable” and hopes it will benefit hundreds of Australians